Cargando…

Is there a role for allogeneic hematopoietic stem cell transplantation for refractory follicular lymphoma?

Detalles Bibliográficos
Autores principales:	Yang, Yang, Bi, Xia, Gergis, Mia, Gergis, Usama
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Editorial Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677175/ https://www.ncbi.nlm.nih.gov/pubmed/36420302 http://dx.doi.org/10.21037/sci-2022-041

Ejemplares similares

The two-step approach to allogeneic hematopoietic stem cell transplantation
por: Ibikunle, Sikemi, et al.
Publicado: (2023)

Outcomes of two-step haploidentical allogeneic stem cell transplantation in elderly patients with hematologic malignancies
por: Bi, Xia, et al.
Publicado: (2022)

Abstract 6 Projected Impact of Omidubicel on Racial and Ethnic Disparities in Allogeneic Hematopoietic Cell Transplant Access and Outcomes for Patients with Hematologic Malignancies in the U.S.
por: Gergis, Usama, et al.
Publicado: (2022)

Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan–Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation
por: Patel, Khilna, et al.
Publicado: (2016)

The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma
por: Min, Gi-June, et al.
Publicado: (2023)

Update on the Role of Autologous Hematopoietic Stem Cell Transplantation in Follicular Lymphoma
por: Cabrero, Mónica, et al.
Publicado: (2012)

Hematopoietic stem cell transplantation for the management of follicular lymphoma
por: Hosing, Chitra
Publicado: (2010)

Reappraising the Role of Allogeneic Hematopoietic Stem Cell Transplantation in Relapsed and Refractory Hodgkin’s Lymphoma: Recent Advances and Outcomes
por: Al-Juhaishi, Taha, et al.
Publicado: (2022)

Development of allogeneic hematopoietic stem cell transplantation in 2022: Regenerating “Groot” to heal the world
por: Lv, Meng, et al.
Publicado: (2023)

The Role of Autologous and Allogeneic Stem Cell Transplantation in Follicular Lymphoma in The New Drugs Era
por: Maura, Francesco, et al.
Publicado: (2016)

Allogeneic Hematopoietic Stem Cell Transplantation in Cutaneous T-Cell Lymphomas
por: Dumont, Maëlle, et al.
Publicado: (2020)

The Role of Allogeneic Stem Cell Transplantation in Relapsed/Refractory Hodgkin's Lymphoma Patients
por: Klyuchnikov, Evgeny, et al.
Publicado: (2011)

Role of Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Hodgkin Lymphoma
por: Carella, Angelo Michele
Publicado: (2012)

Do sophisticated models give the full picture of allogeneic hematopoietic stem cell transplantation effect?
por: Xu, Yujun, et al.
Publicado: (2022)

Salvaged allogeneic hematopoietic stem cell transplantation for pediatric chemotherapy refractory acute leukemia
por: Wang, Jingbo, et al.
Publicado: (2017)

Outcomes associated with allogeneic hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma in the era of novel agents
por: Faisal, Muhammad Salman, et al.
Publicado: (2023)

Allogeneic Hematopoietic Stem Cell Transplantation in Extranodal Natural Killer/T-cell Lymphoma
por: Peng, Yin-yin, et al.
Publicado: (2021)

Allogeneic hematopoietic stem cell transplantation for primary cutaneous T cell lymphomas
por: Paralkar, Vikram R., et al.
Publicado: (2011)

Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
por: Huang, Wen-Rong, et al.
Publicado: (2018)

Attenuated Novel SARS Coronavirus 2 Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient on Ruxolitinib
por: Foss, Francine M., et al.
Publicado: (2020)

Reduced-Intensity Allogeneic Stem Cell Transplantation for Co-Emergence of Chemotherapy-Refractory Follicular Lymphoma and Therapy-Related Myelodysplastic Syndrome
por: Shimura, Yuji, et al.
Publicado: (2014)

Current Role of Autologous and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
por: Castagna, Luca, et al.
Publicado: (2015)

Allogeneic hematopoietic stem-cell transplantation for myelofibrosis
por: Zhang, Lining, et al.
Publicado: (2020)

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation
por: Chen, George L., et al.
Publicado: (2023)

Cost-Effectiveness of Chimeric Antigen Receptor T Cell Therapy in Patients with Relapsed or Refractory Large B Cell Lymphoma: No Impact of Site of Care
por: Cummings Joyner, Alice Kate, et al.
Publicado: (2022)

Clinical Outcomes Associated With Respiratory Virus Detection Before Allogeneic Hematopoietic Stem Cell Transplant
por: Campbell, Angela P., et al.
Publicado: (2015)

Alemtuzumab-BEAM as conditioning for allogeneic hematopoietic stem cell transplantation in relapsed/refractory Hodgkin lymphoma: a single-center analysis
por: Rabitsch, W., et al.
Publicado: (2016)

Case Report: Unedited allogeneic chimeric antigen receptor T cell bridging to conditioning-free hematopoietic stem cell transplantation for a child with refractory Burkitt lymphoma
por: Yang, Xiaomin, et al.
Publicado: (2023)

The Role of Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Leukemia
por: Algeri, Mattia, et al.
Publicado: (2021)

Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2020)

Inhaled Bronchodilators and Corticosteroids in the Management of Bronchiolitis Obliterans due to Allogenic Hematopoietic Stem Cell Transplantation
por: Georgakopoulou, Vasiliki Epameinondas, et al.
Publicado: (2022)

Long-term remission of primary refractory ALK-positive anaplastic large cell lymphoma after allogeneic hematopoietic stem cell transplantation
por: Miyazaki, Masahiro, et al.
Publicado: (2022)

Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis
por: Berning, Philipp, et al.
Publicado: (2023)

Outcomes of allogeneic hematopoietic stem cell transplantation for lymphomas: a single-institution experience
por: Massoud, Mira Romany, et al.
Publicado: (2016)

Progression and CSF Inflammation after Eradication of Oligoclonal Bands in an MS Patient Treated with Allogeneic Hematopoietic Cell Transplantation for Follicular Lymphoma
por: Braendstrup, P., et al.
Publicado: (2012)

Risk‐adapted therapy in follicular lymphoma: Is it time to “FLEX”?
por: Tobin, Joshua W. D., et al.
Publicado: (2020)

Allogeneic transplantation in elderly patients ≥65 years with non-Hodgkin lymphoma: a time-trend analysis
por: Shah, Nirav N., et al.
Publicado: (2019)

Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey
por: Sellner, Leopold, et al.
Publicado: (2021)

The emerging roles of the gut microbiome in allogeneic hematopoietic stem cell transplantation
por: Khuat, Lam T., et al.
Publicado: (2021)

mRNA-1273 SARS-CoV-2 vaccine safety and COVID-19 risk perception in recently transplanted allogeneic hematopoietic stem cell transplant recipients
por: Albiol, Nil, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5q6jtf6vj0vtmueujd3lcdt2p9